• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Presidio Investors Welcomes Javier Saade as New Operating Partner

    9/6/23 8:00:00 AM ET
    $ABT
    $BAH
    $DOCU
    $PRCH
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Professional Services
    Consumer Discretionary
    Get the next $ABT alert in real time by email

    Presidio Investors, a leading middle market private equity firm that capitalizes technology, media, and financial services businesses, is pleased to announce that Javier Saade has joined the firm as Operating Partner. Along with Mark Goldman and Scott Bolick, Javier's unique perspective and expertise will further enhance the firm's strategic investment capabilities and create value across the portfolio. He is a principled leader that has over three decades of broad experience as an investor, board member, founder, operating executive, and former policymaker.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230906464989/en/

    Javier Saade (Photo: Business Wire)

    Javier Saade (Photo: Business Wire)

    Karl Schade, Managing Partner, said, "We are thrilled to welcome Javier to our team as our newest operating partner. With an exceptional background in strategy, policy, and operations, he brings a wealth of expertise that will undoubtedly elevate our firm's capabilities. We are excited to collaborate with Javier as we continue to navigate the dynamic landscape of our industry, driving innovation and delivering unparalleled value to our clients."

    Javier recently served as Audit Committee Chair of the Board of SoftBank Vision Fund Investment Corp. (NASDAQ:SVFA), Lead Independent Director of Porch Group, Inc. (NASDAQ:PRCH), Member of the Boards of Advisors of DocuSign, Inc. (NASDAQ:DOCU) and Univision Communications, and Member of the Boards of Trustees of The Nature Conservancy and Pan American Development Foundation. Earlier in his career, he held leadership, operational and investing roles at McKinsey & Company, Booz Allen & Hamilton (NYSE:BAH), Bridgewater Associates (a hedge fund with $160 billion in assets), Paradigm Ventures, Abbott Laboratories (NYSE:ABT), and Air America, a media company he co-founded. He also held a position of public trust as Associate Administrator, Chief of Investment and Innovation of the U.S. Small Business Administration (SBA) leading programs that have invested $120 billion in over 300,000 high growth companies and cutting-edge technologies. In addition, Javier concurrently served on the Committee for Small & Emerging Companies of the U.S. Securities & Exchange Commission (SEC), subsequently served on the Presidential Transition at the Department of Treasury, and currently serves on the Advisory Committee on Trade Policy & Negotiations at the White House.

    "I've known the Managing Partners of Presidio for decades and joining forces with them made all the sense in the world. The entire team's focus on enhancing company operations, driving growth, and creating value is notable and I look forward to helping the firm and its portfolio companies reach their potential," said Javier about joining Presidio.

    Currently he is Chairman of the Board of GP Funding, Inc., a Presidio portfolio company and leading specialty finance company focused on the legal and healthcare sectors. He is also Managing Partner of Impact Master Holdings, Venture Partner at Fenway Summer, Contributor at CNBC, and Executive Fellow at Harvard Business School.

    About Presidio Investors

    Presidio Investors is a leading Austin, Texas-based private equity firm investing in quality businesses in the lower middle market. With a proven history of successful investments, the firm partners with exceptional management teams to create long-term value and achieve superior financial results. Presidio Investors is committed to identifying and capitalizing on compelling investment opportunities that offer significant growth potential. For more information, please visit www.presidioinvestors.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20230906464989/en/

    Get the next $ABT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABT
    $BAH
    $DOCU
    $PRCH

    CompanyDatePrice TargetRatingAnalyst
    DocuSign Inc.
    $DOCU
    4/10/2026$50.00Buy → Neutral
    Citigroup
    Booz Allen Hamilton Holding Corporation
    $BAH
    4/1/2026$85.00Equal Weight
    Wells Fargo
    DocuSign Inc.
    $DOCU
    3/31/2026$52.00Underperform
    BofA Securities
    DocuSign Inc.
    $DOCU
    2/23/2026$45.00Buy → Hold
    Jefferies
    Porch Group Inc.
    $PRCH
    2/11/2026$10.50Mkt Perform → Outperform
    Keefe Bruyette
    DocuSign Inc.
    $DOCU
    12/17/2025$88.00Buy
    BTIG Research
    Booz Allen Hamilton Holding Corporation
    $BAH
    12/12/2025$93.00Neutral
    Citigroup
    Booz Allen Hamilton Holding Corporation
    $BAH
    10/24/2025$90.00Buy → Underperform
    BofA Securities
    More analyst ratings

    $ABT
    $BAH
    $DOCU
    $PRCH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    DocuSign downgraded by Citigroup with a new price target

    Citigroup downgraded DocuSign from Buy to Neutral and set a new price target of $50.00

    4/10/26 8:29:33 AM ET
    $DOCU
    Computer Software: Prepackaged Software
    Technology

    Wells Fargo initiated coverage on Booz Allen Hamilton with a new price target

    Wells Fargo initiated coverage of Booz Allen Hamilton with a rating of Equal Weight and set a new price target of $85.00

    4/1/26 8:29:05 AM ET
    $BAH
    Professional Services
    Consumer Discretionary

    BofA Securities resumed coverage on DocuSign with a new price target

    BofA Securities resumed coverage of DocuSign with a rating of Underperform and set a new price target of $52.00

    3/31/26 8:11:11 AM ET
    $DOCU
    Computer Software: Prepackaged Software
    Technology

    $ABT
    $BAH
    $DOCU
    $PRCH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Booz Allen Hamilton to Host Conference Call to Discuss Fourth Quarter and Full Year Fiscal 2026 Results on Friday, May 22, 2026

    Booz Allen Hamilton Holding Corporation (NYSE:BAH), the parent company of advanced technology company Booz Allen Hamilton Inc., will host a conference call at 8 a.m. EDT on Friday, May 22, 2026, to discuss the financial results for the Fourth Quarter and Full Year of Fiscal 2026 (ending March 31, 2026). A news release containing the results will be issued before the call. Analysts and institutional investors may participate by registering online at investors.boozallen.com. Participants are requested to register a minimum 15 minutes before the start of the call. The conference call will be webcast simultaneously to the public through a link on the investor relations section of the Booz A

    4/10/26 6:45:00 AM ET
    $BAH
    Professional Services
    Consumer Discretionary

    New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their health

    With chronic disease on the rise, a new survey from Abbott shows information overload, confusion and cost leave many Americans struggling, worrying about how to stay healthyABBOTT PARK, Ill., April 9, 2026 /PRNewswire/ -- Today, Abbott (NYSE:ABT), a global leader in chronic disease prevention, treatment and care, is releasing new survey findings highlighting a growing tension: 74% of U.S. adults believe most chronic diseases, such as diabetes or cardiovascular disease, are preventable, but only 1 in 4 feel very confident in knowing how to care for their health. In the U.S. alone, three in four American adults have at least one chronic condition1. With chronic disease continually on the rise2

    4/9/26 9:00:00 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Booz Allen Advances Orbital Warfare for Space Domain

    Investment in Portal Space Systems supports secure next-generation space capabilities with speed, cost efficiency, and maneuverability Booz Allen Hamilton (NYSE:BAH) today announced that its corporate venture capital arm, Booz Allen Ventures, has invested in Portal Space Systems, a U.S.-based space technology company developing rapidly maneuverable spacecraft for next-generation orbital operations. Portal Space Systems is developing a new class of maneuverable spacecraft, including Starburst—its orbital maneuvering vehicle designed to provide rapid, responsive operations within a destination orbit—and Supernova—its transorbital spacecraft built for movement across orbital regimes. Toget

    4/9/26 9:00:00 AM ET
    $BAH
    Professional Services
    Consumer Discretionary

    $ABT
    $BAH
    $DOCU
    $PRCH
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 24, 2023 - FDA Approves New Therapy for Rare Form of Blood Cancers Called Myelodysplastic Syndromes

    For Immediate Release: October 24, 2023 Today, the U.S. Food and Drug Administration approved Tibsovo (ivosidenib) for the treatment of adult patients with relapsed or refractory (R/R) myelodysplastic syndromes (MDS) with an isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test. This is the first targeted therapy approved for this indication. The agency also approved the Abbott RealTime

    10/24/23 3:52:17 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    $BAH
    $DOCU
    $PRCH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Starks Daniel J bought $1,087,331 worth of Common shares without par value (10,000 units at $108.73), increasing direct ownership by 0.15% to 6,738,817 units (SEC Form 4)

    4 - ABBOTT LABORATORIES (0000001800) (Issuer)

    2/6/26 8:04:16 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CHAIRMAN AND CEO Ford Robert B bought $2,013,967 worth of Common shares without par value (18,800 units at $107.13) (SEC Form 4)

    4 - ABBOTT LABORATORIES (0000001800) (Issuer)

    1/26/26 8:02:24 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President and CEO Rozanski Horacio bought $2,014,908 worth of shares (23,800 units at $84.66), increasing direct ownership by 4% to 687,745 units (SEC Form 4)

    4 - Booz Allen Hamilton Holding Corp (0001443646) (Issuer)

    10/30/25 8:39:06 PM ET
    $BAH
    Professional Services
    Consumer Discretionary

    $ABT
    $BAH
    $DOCU
    $PRCH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Ehrlichman Matt

    4 - Porch Group, Inc. (0001784535) (Issuer)

    4/10/26 5:55:07 PM ET
    $PRCH
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Tabak Shawn

    4 - Porch Group, Inc. (0001784535) (Issuer)

    4/10/26 5:54:18 PM ET
    $PRCH
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Neagle Matthew

    4 - Porch Group, Inc. (0001784535) (Issuer)

    4/10/26 5:53:30 PM ET
    $PRCH
    Computer Software: Prepackaged Software
    Technology

    $ABT
    $BAH
    $DOCU
    $PRCH
    SEC Filings

    View All

    SEC Form 144 filed by Porch Group Inc.

    144 - Porch Group, Inc. (0001784535) (Subject)

    4/8/26 7:43:43 AM ET
    $PRCH
    Computer Software: Prepackaged Software
    Technology

    SEC Form 144 filed by Porch Group Inc.

    144 - Porch Group, Inc. (0001784535) (Subject)

    4/2/26 7:42:35 AM ET
    $PRCH
    Computer Software: Prepackaged Software
    Technology

    SEC Form 144 filed by DocuSign Inc.

    144 - DOCUSIGN, INC. (0001261333) (Subject)

    4/1/26 4:32:12 PM ET
    $DOCU
    Computer Software: Prepackaged Software
    Technology

    $ABT
    $BAH
    $DOCU
    $PRCH
    Leadership Updates

    Live Leadership Updates

    View All

    CRH, Carvana and Comfort Systems USA Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, Dec. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, December 22, to coincide with the quarterly rebalance. The changes ensure that each index is more representative of its market capitalization range. The companies being removed from the S&P SmallCap 600 are no longer representative of the small-cap market space.  Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector Dec 22, 2025  S&P 500 Addition CRH CRH Mat

    12/5/25 5:49:00 PM ET
    $ASIX
    $BAH
    $BWA
    Major Chemicals
    Industrials
    Professional Services
    Consumer Discretionary

    Pipedrive Appoints Regi Vengalil as CFO to Drive Next Stage of AI-Native Growth

    Pipedrive, the easy and effective sales CRM for small companies, today announced the appointment of Regi Vengalil as the company's new Chief Financial Officer. Vengalil brings nearly two decades of financial and strategic leadership experience from high-growth SaaS, fintech, and AI-driven companies, guiding companies through complex market landscapes and driving clarity and discipline in financial operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251202982724/en/Pipedrive appoints Regi Vengalil as CFO to drive next stage of AI-native growth Vengalil joins Pipedrive from Trax Retail, a leader in AI image recognition softw

    12/2/25 7:00:00 AM ET
    $PRCH
    Computer Software: Prepackaged Software
    Technology

    SHARON AI To Appoint Mr Drew Kelton To Board of Directors

    SHARON AI, Inc. ("SHARON AI"), Australia's leading Neocloud, is pleased to announce that highly experienced global technology executive Mr Drew Kelton has agreed to join the Sharon AI Holdings Inc board of directors. Mr Kelton is a global business leader and professional board director. With 40 years' experience in the information and communications technology arena, he has held senior roles in the UK, Europe, India, Australasia and the US. "SHARON AI is building the next generation of sovereign AI and digital infrastructure, and I'm excited to be part of a company with both the vision and capability to lead this transformation," said Drew Kelton. Mr Kelton was previously Chief Executive

    12/1/25 3:06:00 PM ET
    $DOCU
    $TMUS
    Computer Software: Prepackaged Software
    Technology
    Telecommunications Equipment
    Telecommunications

    $ABT
    $BAH
    $DOCU
    $PRCH
    Financials

    Live finance-specific insights

    View All

    Booz Allen Hamilton to Host Conference Call to Discuss Fourth Quarter and Full Year Fiscal 2026 Results on Friday, May 22, 2026

    Booz Allen Hamilton Holding Corporation (NYSE:BAH), the parent company of advanced technology company Booz Allen Hamilton Inc., will host a conference call at 8 a.m. EDT on Friday, May 22, 2026, to discuss the financial results for the Fourth Quarter and Full Year of Fiscal 2026 (ending March 31, 2026). A news release containing the results will be issued before the call. Analysts and institutional investors may participate by registering online at investors.boozallen.com. Participants are requested to register a minimum 15 minutes before the start of the call. The conference call will be webcast simultaneously to the public through a link on the investor relations section of the Booz A

    4/10/26 6:45:00 AM ET
    $BAH
    Professional Services
    Consumer Discretionary

    Abbott hosts conference call for first-quarter earnings

    ABBOTT PARK, Ill., March 26, 2026 /PRNewswire/ -- Abbott (NYSE:ABT) will announce its first-quarter 2026 financial results on Thursday, April 16, before the market opens. The announcement will be followed by a live webcast of the earnings conference call at 8 a.m. Central time (9 a.m. Eastern) and will be accessible through Abbott's Investor Relations website at www.abbottinvestor.com. An archived edition of the call will be available later that day.About Abbott: Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical

    3/26/26 9:00:00 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Abbott completes acquisition of Exact Sciences

    Establishes Abbott as a leader in fast-growing cancer screening and diagnostics segmentsAdvances Abbott's mission to make healthcare more accessible and give people more control over their healthABBOTT PARK, Ill., March 23, 2026 /PRNewswire/ -- Abbott (NYSE:ABT) today announced it has completed the acquisition of Exact Sciences, establishing Abbott as a leader in fast-growing cancer screening and diagnostics segments and enabling the company to serve millions of additional people. "Abbott's global scale, track record of operational and commercial excellence and work with healthcare systems around the world will expand access to important tools for early cancer detection and personalized trea

    3/23/26 8:50:00 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    $BAH
    $DOCU
    $PRCH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Porch Group Inc.

    SC 13G/A - Porch Group, Inc. (0001784535) (Subject)

    11/14/24 4:17:30 PM ET
    $PRCH
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Booz Allen Hamilton Holding Corporation

    SC 13G/A - Booz Allen Hamilton Holding Corp (0001443646) (Subject)

    11/14/24 1:22:34 PM ET
    $BAH
    Professional Services
    Consumer Discretionary

    SEC Form SC 13G/A filed by Porch Group Inc. (Amendment)

    SC 13G/A - Porch Group, Inc. (0001784535) (Subject)

    2/14/24 11:24:46 AM ET
    $PRCH
    Computer Software: Prepackaged Software
    Technology